RecruitingNot ApplicableNCT06237127

Effects of Goji vs. Fiber on Macular Degeneration

Effects of Goji Berry Intake on Risk of Age-related Macular Degeneration: A Randomized Clinical Trial


Sponsor

University of California, Davis

Enrollment

60 participants

Start Date

Apr 29, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

The goal of this project is to conduct a clinical trial in 60 participants ranging from age 65-95 who are at risk for age-related macular degeneration (AMD). The study will evaluate the effects of 14g of goji berry intake or an equivalent amount and type of fiber, five days a week for six months, on visual health, gut microbiome profiles, skin carotenoid measures, and lipoprotein profiles.


Eligibility

Min Age: 65 YearsMax Age: 95 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Fiber and Goji berry for people with age-related macular degeneration. The study is currently recruiting participants at 1 location. People eligible for this study include aged 65 Years to 95 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTGoji berry

Participants will be instructed to consume 14 grams of goji berries 5 days a week for 6 months

DIETARY_SUPPLEMENTFiber

Participants will be instructed to consume the fiber supplements 5 days a week for 6 months


Locations(1)

UC Davis Eye Center, Tschannen Eye Institute

Sacramento, California, United States

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06237127


Related Trials